Systemic Delivery of Antisense Oligomer in Animal Models and Its Implications for Treating DMD
Page 1 of 1
Systemic Delivery of Antisense Oligomer in Animal Models and Its Implications for Treating DMD
Jon Moulton Thu Mar 29, 2012 12:31 pm
Lu QL, Wu B. Systemic Delivery of Antisense Oligomer in Animal Models and Its Implications for Treating DMD. Methods Mol Biol. 2012;867:393-405.
Jon Moulton- Posts : 5721
Join date : 2010-03-12
Age : 61
Location : Philomath, Oregon, USA -
Similar topics» Identification of a Peptide for Systemic Brain Delivery of a Morpholino Oligonucleotide in Mouse Models of Spinal Muscular Atrophy
» Bodywide skipping of exons 45–55 in dystrophic mdx52 mice by systemic antisense delivery
» Cell-penetrating peptides enhance systemic delivery of antisense morpholino oligomers
» Plasmonic laser treatment for Morpholino oligomer delivery in antisense applications
» Evaluation of Tris[2-(acryloyloxy)ethyl]isocyanurate Cross-linked Polyethylenimine as Antisense Morpholino Oligomer Delivery Vehicle in Cell Culture and Dystrophic mdx Mice
» Bodywide skipping of exons 45–55 in dystrophic mdx52 mice by systemic antisense delivery
» Cell-penetrating peptides enhance systemic delivery of antisense morpholino oligomers
» Plasmonic laser treatment for Morpholino oligomer delivery in antisense applications
» Evaluation of Tris[2-(acryloyloxy)ethyl]isocyanurate Cross-linked Polyethylenimine as Antisense Morpholino Oligomer Delivery Vehicle in Cell Culture and Dystrophic mdx Mice
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum|
|
|